Join to View Full Profile
3959 Broadway21 Audubon AvenueNew York, NY 10032
Phone+1 212-854-2091
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Ann Anderson is a pediatrician specializing in Adolescent Medicine, based in New York, NY. She completed her medical education at Icahn School of Medicine at Mount Sinai in 2015 and her residency at New York Presbyterian Hospital (Columbia Campus), where she also served as Chief Resident. She pursued a fellowship in Adolescent Medicine at the same institution. Dr. Anderson has published several research articles, notably on topics such as autism spectrum disorder and substance use disorder risk in adolescents and neuropsychiatric effects of synthetic cannabinoids in adolescents, achieving notable citations in esteemed journals.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Adolescent Medicine, 2019 - 2021- New York Presbyterian Hospital (Columbia Campus)Chief Residency, Pediatrics, 2018 - 2019
- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2015 - 2018
Icahn School of Medicine at Mount SinaiClass of 2015
Certifications & Licensure
NY State Medical License 2016 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Adolescent Medicine
Publications & Presentations
PubMed
- 3 citationsAutism Spectrum Disorder and the Risk of Substance Use Disorder: A Call for Targeted Screening and Prevention in Adolescents.Sarah Ann R. Anderson, Marina Catallozzi
JAMA Pediatrics. 2021-02-01 - 15 citationsNeuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.Sarah Ann R. Anderson, Anna M. Oprescu, Diane P. Calello, Andrew A. Monte, Peter S. Dayan
Pediatrics. 2019-08-01 - 13 citationsA Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Rewa...Gabor Egervari, Didier Jutras-Aswad, Joseph A. Landry, Michael L. Miller, Sarah Ann R. Anderson
Neuropsychopharmacology. 2016-04-14
Press Mentions
Seizures, Coma More Common With Synthetic Cannabinoids in AdolescentJuly 2nd, 2020
Not Concerned About Teen Patients Using Synthetic Cannabinoids? This Study of Their Toxicity Will Make That Happen!July 2nd, 2020
Synthetic Cannabinoids Associated with Comas and Seizures in TeensJuly 2nd, 2020- Join now to see all
Professional Memberships
- Fellow
- Society of Adolescent Health and MedicineMember
- National Medical AssociationMember
- Student National Medical AssociationMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
